Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10138462 Natural killer cell lines and methods of use

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 7, 2001
0
Date of Patent
November 27, 2018
0
Patent Application Number
10008955
0
Patent Citations Received
‌
US Patent 12109238 Chimeric antigen receptor-modified NK-92 cells
0
‌
US Patent 11643452 Fc-epsilon car
0
‌
US Patent 11753625 Modified NK-92 haNK003 cells for the clinic
‌
US Patent 11992504 Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment
0
‌
US Patent 12085571 Biological deposit labeling and tracking including isotope, rare earth metal or mitochondria tags
0
‌
US Patent 11230699 Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors
‌
US Patent 11547727 Chimeric antigen receptor-modified NK-92 cells
‌
US Patent 10774310 Modified NK-92 haNK003 cells for the clinic
‌
US Patent 10801013 Modified NK-92 haNK003 cells for the clinic
0
‌
US Patent 10960024 Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
•••
Patent Inventor Names
Hans Klingemann
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10138462
0
Patent Primary Examiner
‌
Michael Szperka
0

Find more entities like US Patent 10138462 Natural killer cell lines and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo